During Tuesday’s Best of ASGE DDW en Español session, gastroenterology experts from Spanish-speaking countries will summarize the top endoscopic sessions at DDW® in five topic areas.
Clostridium difficile colitis does not happen in a vacuum. When, why and how C. diff populations explode and cause colitis is the result of a complex interplay among bacteria, human host, the gut microbiome and the environment.
The ASGE International Program at DDW® culminates on Tuesday with four joint symposia, including concurrent sessions with the Australian Gastrointestinal Endoscopy Association (AGEA) and the Chinese Society of Gastroenterology (CSGE).
CRC screening guidelines vary around the world. The U.S. is one of the only countries, for example, that relies heavily on colonoscopies for CRC screening in average-risk populations. Other countries tend to rely on less expensive and less invasive screening technologies for average-risk screening.
Andrew P. Keaveny, MD, FRCPI, FAASLD
Consultant Hepatologist and Medical Director of Liver Transplant, Mayo Clinic, Jacksonville, Florida; Associate Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, AASLD Annual Meeting Education Committee; Member of the AASLD Maintenance of Certification and Scientific Planning Committees
Two new strategies are emerging to treat GI and other cancers — engineered T cells and immune checkpoint blockade treatments.
‘Your life’s work should be fun. If it’s nothing more than a job, it’s time to find your passion.
That was the message from SSAT President Nathaniel J. Soper, MD, who recounted his professional journey Sunday morning at DDW® during the annual SSAT Presidential Address.
Caring for patients with IBD requires a multidisciplinary approach. So the organizers of Tuesday’s DDW® Clinical Symposium Endoscopic and Surgical Principles in IBD set out to create a multidisciplinary educational program. The 90-minute symposium is jointly sponsored by AGA, ASGE and SSAT.
Physician innovators must be determined, entrepreneurial to get a medical device or technology to market
Have an idea for a new medical device, technology or service? Getting it to market is a complex, time-consuming process that requires analytical and management skills, great communication, collaboration and leadership, according to Virender Sharma, MD, AGAF, who shared lessons he’s learned as a physician innovator on Saturday at DDW® during a session sponsored by the AGA Center for GI Innovation and Technology.
The management of hepatocellular cancer (HCC) saw meaningful advances in 2016 with the introduction of two compounds, regorafenib and lenvatinib, for patients with advanced HCC.